Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Objective Insulin resistance and nonalcoholic fatty liver disease have been linked to several lipid metabolites in animals, but their role in humans remains unclear. This study examined the relationship of sphingolipids with hepatic and peripheral metabolism in 21 insulin-resistant obese patients without (NAFL-) or with (NAFL+) nonalcoholic fatty liver and nonalcoholic steatohepatitis (NASH) and 7 healthy lean individuals undergoing tissue biopsies during bariatric or elective abdominal surgery. Research design and methods Hyperinsulinemic-euglycemic clamps with d-[6,6- 2 H 2 ]glucose were performed to quantify tissue-specific insulin sensitivity. Hepatic oxidative capacity, lipid peroxidation, and the phosphorylated-to-total c-Jun N-terminal kinase (pJNK-to-tJNK) ratio were measured to assess mitochondrial function, oxidative stress, and inflammatory activity. Results Hepatic total ceramides were higher by 50% and 33% in NASH compared with NAFL+ and NAFL-, respectively. Only in NASH were hepatic dihydroceramides (16:0, 22:0, and 24:1) and lactosylceramides increased. Serum total ceramides and dihydroceramides (hepatic dihydroceramides 22:0 and 24:1) correlated negatively with whole-body but not with hepatic insulin sensitivity. Hepatic maximal respiration related positively to serum lactosylceramide subspecies, hepatic sphinganine, and lactosylceramide 14:0. Liver lipid peroxides (total ceramides, sphingomyelin 22:0) and the pJNK-to-tJNK ratio (ceramide 24:0; hexosylceramide…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With increasing hepatic lipid accumulation, the generation of toxic lipid intermediates (diacylglycerols, ceramides) and altered hepatic mitochondrial respiration rates drive hepatic insulin resistance, inflammation and oxidative stress -all of them fueling pro-fibrotic pathways (Fig. 1) [26,27].”
From Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease? (2024) · cites this paper as [27]
In the citing paper
“Patients with MASH have 20% higher ceramide concentrations compared to healthy individuals.100,102,104,117”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [100]
In the citing paper
“High levels of plasma ceramides are correlated with the severity of MASLD and reflect hepatic ceramide accumulation.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [100]
In the citing paper
“Ceramides are among the most studied lipids because of their lipotoxic activity in several organs and have been reported to be increased in the plasma of patients with MASLD.94,[99], [100], [101], [102],[107], [108], [109],115”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [100]
In the citing paper
“Among ceramides, in a small cohort of seven patients, Apostolopoulou et al.100 showed that total ceramides, as well as lactosyl-, hexosyl-, and dihydro-ceramides were significantly increased in MASH”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [100]
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Sphingolipid metabolites in inflammatory disease
Maceyka, M., & Spiegel, S. (2014) · Nature · doi:10.1038/nature13475 · Cited by 1,277 · cited 3×
“HDL-cholesterol (mg/dL) 64 (57, 83)¶,# 44 (35, 54) 35 (33,45) 52 (43, 59)”
BackgroundKoliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032
Self-citationTilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002 · cited 8×
“The NAFL+ group included one participant with T2D.”
BackgroundMethodInfluentialSelf-citationReceptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892 · cited 1×
“Rodent studies using a high-fat diet or in leptin-deficientob/obmicehave shown controversial resultsfortherelationshipof hepatic accumulation of ceramides with hepatic insulin sensitivity (26,27).”
BackgroundSelf-citationSunny, N. E., Parks, E. J., Browning, J. D., & Burgess, S. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.004 · Cited by 672 · cited 2×
“Of note, obese people have increased hepatic mitochondrial capacity (10,11), which declines in nonalcoholicsteatohepatitis (NASH)along”
BackgroundHaus, J. M., Kashyap, S. R., Kasumov, T., Zhang, R., Kelly, K. R., DeFronzo, R. A., & Kirwan, J. P. (2009) · Diabetes · doi:10.2337/db08-1228 · Cited by 663
Ceramides – Lipotoxic Inducers of Metabolic Disorders
Chaurasia, B., & Summers, S. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.07.006 · Cited by 616
The role of mitochondria in insulin resistance and type 2 diabetes mellitus
Szendroedi, J., Phielix, E., & Roden, M. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.138 · Cited by 600
Self-citationCellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Kumashiro, N., Erion, D. M., Zhang, D., Kahn, M., Beddow, S. A., Chu, X., Still, C. D., Gerhard, G. S., Han, X., Dziura, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113359108 · Cited by 585 · cited 1×
“Liver total ceramides did not relate to whole-body insulin sensitivity, extending previous findings using HOMA-insulin resistanceasasurrogateof insulinresistance (5).”
Background
Cited by
Items 201–286 of 286
Scopoletin Induced Metabolomic Profile Disturbances in Zebrafish Embryos
Yao, W., Chen, J., Lin, Z., Wang, N., Wang, A., Wang, B., Wu, Y., Xu, Z., & Wang, J. (2022) · Metabolites · doi:10.3390/metabo12100934 · Cited by 7
“The dysfunction of sphingolipid metabolism always occurs under oxidative stress [27].”
BackgroundHou, Y., Deng, F., Guo, J., Lv, L., OuYang, H., Wang, X., Luo, Y., Chen, X., & Wang, F. (2023) · Endocrinology · doi:10.1210/endocr/bqad084 · Cited by 7
Bódis, K. B., Bombrich, M., Schön, M., Knebel, B., Zaharia, O., Bönhof, G. J., Karusheva, Y., Straßburger, K., Kupriyanova, Y., Kotzka, J., et al. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.06.004 · Cited by 8
Self-citationKalopitas, G., Mouskeftara, T., Liapikos, T., Arvanitakis, K., Ioannidis, A., Malandris, K., Theocharidou, E., Chourdakis, M., Sinakos, E., Gika, H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612717 · Cited by 7
“[9] conducted a prospective study including bariatric patients.”
BackgroundLong-term effects on liver metabolism induced by ceftriaxone sodium pretreatment
Lai, C., Chen, L., Zhong, X., Tang, Z., Zhang, B., Luo, Y. H., Li, C., Jin, M., Chen, X., Li, J., et al. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.122238 · Cited by 9
Solano-Aguilar, G. I., Lakshman, S., Jang, S., Gupta, R., Molokin, A., Schroeder, S., Gillevet, P. M., & Urban, J. F. (2021) · Metabolites · doi:10.3390/metabo11110779 · Cited by 8
“While our study of metabolite composition in response to WBM dietary supplementation in healthy pigs was not designed to indicate whether WBM prevents disease, there is support for a beneficial role of eating WBM to promote host health through increased amino acid that serve as precursors for neurotransmitters in the…”
BackgroundEffect of diet and genotype on the lipidome of mice with altered lipoprotein metabolism
Busnelli, M., Manzini, S., Colombo, A., Franchi, E., Lääperi, M., Laaksonen, R., & Chiesa, G. (2024) · iScience · doi:10.1016/j.isci.2024.111051 · Cited by 6
Overexpression of ORMDL3 confers sexual dimorphism in diet-induced non-alcoholic steatohepatitis
Brown, R. D. R., Green, C. D., Weigel, C., Ni, B., Celi, F. S., Proia, R. L., & Spiegel, S. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101851 · Cited by 6
GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD
Jiang, H., & Zang, L. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128283153231226103218 · Cited by 7
Mucinski, J. M., McCaffrey, J. M., Rector, R. S., Kasumov, T., & Parks, E. J. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100366 · Cited by 5
Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis
Kahl, S., Pützer, J., & Roden, M. (2022) · Seminars in Liver Disease · doi:10.1055/s-0041-1732354 · Cited by 5
Self-citationWang, Y., Yuan, H., Chen, X., & Zeng, T. (2021) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2021.100015 · Cited by 5
Amitriptyline inhibits NLRP3 inflammasome activation via the ASM/CE pathway in a cell model of NAFLD
Liu, Q., Niu, C.-Y., Zhang, Q., SUN, S., Chen, Y., & SHI, Y. (2024) · Biocell · doi:10.32604/biocell.2024.048551 · Cited by 5
Rosqvist, F., Cedernaes, J., Mora, A. M., Fridén, M., Johansson, H.-E., Iggman, D., Larsson, A. O., Ahlström, H. K., Kullberg, J., & Risérus, U. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.04.010 · Cited by 5
Bertran, L., Capellades, J., Abelló, S., & Richart, C. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318557 · Cited by 5
HBOT alleviates diet-induced MASH by reprograming gut microbiota and liver metabolism in mice
Chen, L., Xu, S., Zhou, Q., Zhao, T., Zhao, Y., Chen, X., Zhu, W., Ding, J., Zheng, H., Jiang, M., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.05.420 · Cited by 5
Xu, B., Xin, S., Qu, J. T., & Xu, N. (2019) · Environmental Disease · doi:10.4103/ed.ed_24_19 · Cited by 5
Liver–Spleen Ratio: Can It Be Used for the Prediction of Coronary Artery Disease?
Poyraz, N., Özer, H., Baloğlu, İ., Kadıyoran, C., Yılmaz, P. D., Sertdemir, A. L., & Türkmen, K. (2022) · The Anatolian Journal of Cardiology · doi:10.5152/anatoljcardiol.2022.1787 · Cited by 5
Manifold Roles of Ceramide Metabolism in Non-Alcoholic Fatty Liver Disease and Liver Cancer
Wang, K., Wei, Y., Xu, R., Li, Y., & Mao, C. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-0394-6_11 · Cited by 7
Cho, Y., Chang, Y., Ryu, S., Wild, S. H., & Byrne, C. D. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15466 · Cited by 5
NAFLD and Insulin Resistance: A Multisystemic Disease
Gastaldelli, A. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_4 · Cited by 4
Toh, D. W. K., Zhou, H., Cazenave‐Gassiot, A., Choi, H., Burla, B., Bendt, A. K., Wenk, M. R., Ling, L. H., & Kim, J. E. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1258570 · Cited by 4
No Difference in Liver Damage Induced by Isocaloric Fructose or Glucose in Mice with a High-Fat Diet
Hsu, W., Lee, M.-H., Lii, C., & Peng, C. (2024) · Nutrients · doi:10.3390/nu16203571 · Cited by 4
“Increased levels of total hepatic ceramides, including C16:0, C22:0, and C24:1 dihydroceramides, were observed in patients with MASH [17].”
BackgroundZuarth-Vázquez, J. M., Moreno-Castañeda, L., Soriano-Márquez, J. P., Velázquez-Alemán, A. P., Ramos-Ostos, M. H., Uribe, M., López-Méndez, I., & Juárez-Hernández, E. (2023) · Life · doi:10.3390/life13041048 · Cited by 4
“Furthermore, higher levels of proinflammatory adipokines contribute to hepatic inflammation and fibrosis [37,38].”
BackgroundBai, L., Zhang, M., Chen, S., Chen, W., Li, Z., Yue, J., Dong, C., & Li, R. (2023) · Atmosphere · doi:10.3390/atmos15010032 · Cited by 4
Shaojun, Y., Yan-hua, M., Zhouxia, B., Ye, Y., Bu-wu, F., Li, Z., & Li, W. (2024) · PubMed Central · doi:10.19852/j.cnki.jtcm.20231215.002 · Cited by 4
Somvanshi, P. R., Mellon, S. H., Flory, J. D., Amara, D. A., Wolkowitz, O. M., Yehuda, R., Jett, M., Marmar, C. R., Doyle, F. J., Hood, L., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/492827 · Cited by 4
Deficiency of Ugcg in LSECs alleviates high-fat diet-induced MASLD
Han, R., Li, Y., Liu, Y., Li, M., Ren, L., Lin, W., & Jiang, Y. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000793 · Cited by 3
“[22,23] UDP-glucose ceramide glucosyltrans-ferase (UGCG), a pivotal enzyme in GSLs biosynthesis, functions as a glycosyltransferase that catalyzes the initial step of glucosylceramide synthesis.”
Metabolic effects and biotransformation of perfluorohexyloctane in human hepatocytes
Alijagić, A., Chaker, J., Barbosa, J. M. G., Duberg, D., Castro‐Alves, V., Dickens, A. M., Orešič, M., & Hyötyläinen, T. (2026) · Environment International · doi:10.1016/j.envint.2026.110112 · Cited by 3
Sehgal, R., Jähnert, M., Lazaratos, M., Speckmann, T., Schumacher, F., Kleuser, B., Ouni, M., Jonas, W., & Schürmann, A. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100767 · Cited by 3
“The liver sphingo-lipids dCer(22:0) and dCer(24:1) are known to be negatively correlated with whole-body insulin sensitivity and hCer(22:0) and lCer(24:0) with liver inflammation (48).”
Li, H., Niu, L., Wang, M., Liu, C., Wang, Y., Su, Y., & Yang, Y.-B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35491 · Cited by 3
“It is well known that oxidative stress plays an important role in the progression of NAFLD, type 2 diabetes and other metabolic diseases [64].”
BackgroundShortcomings, limitations and gaps in physiological roles of extracellular vesicles in obesity
Valero, P., Silva, K., Valenzuela‐Hinrichsen, A., Vasquez, A. O., Espinoza, F., Lira, F., Cornejo, M., Fuentes, G. A., González, D. R., Moore‐Carrasco, R., et al. (2024) · The Journal of Physiology · doi:10.1113/jp286955 · Cited by 3
“Elevated levels of lactosylceramide have been associated with P. Valero and others J Physiol 604.11 reduced insulin sensitivity, increased oxidative stress and liver inflammation in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) (Apostolopoulou et al., 2018).”
InfluentialMetabolic Syndrome and Metabolic Dysfunction‐Associated Fatty Liver Disease
Koo, B. K., & Lim, S. K. (2022) · Wiley eBooks · doi:10.1002/9781119695257.ch13 · Cited by 3
Hou, Y., Jiao, Y., Zhang, X., & Fang, C. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.105861 · Cited by 2
Interorgan crosstalk in metabolic dysfunction-associated steatotic liver disease
Yang, R., Fang, Z., He, F., & Wang, L. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003927 · Cited by 3
“88–90] Dysfunction of adipose tissue is a significant contributor to elevated systemic sphingolipid levels.”
Carli, F., Guerra, S., Mateus, I., Ducoli, R., Sabatini, S., Pezzica, S., Scoditti, E., Dewalle, C., Lenoir, V., Prip‐Buus, C., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.04.031 · Cited by 2
Role of Mitochondria in the Liver Metabolism in Obesity and Type 2 Diabetes
Katsuyama, H., Czeczor, J. K., & Roden, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811752-1.00008-0 · Cited by 2
Self-citationThe 340B Discount Drug Program At Ozarks Medical Center: An Economic Stimulus Plan for Missouri.
Barlas, S. (2011) · PubMed · Cited by 2
Imaging in Precision Medicine for Diabetes
Zaharia, O., Schrauwen‐Hinderling, V. B., & Roden, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_4 · Cited by 1
Self-citationSourianarayanane, A., Brydges, C. R., & McCullough, A. J. (2025) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.70069 · Cited by 1
Plasma sphingolipids predict advanced liver fibrosis development in patients with type 2 diabetes
Béland‐Bonenfant, S., Denimal, D., de Barros, J.-P. P., Choubley, H., Rouland, A., Simoneau, I., Duvillard, L., Aho, S., Bouillet, B., Petit, J., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70156 · Cited by 2
“20 However, these studies investigated cross-sectionally the association between dhCER d18:0/20:0 and liver outcomes, whereas we investigated the relationship between baseline lipidome and future AF in our study.”
Ma, T., Li, M., Liu, Y., Chen, Y., Guan, Z., Liu, T., Qin, D., & Xu, J. (2025) · Nutrients · doi:10.3390/nu17243849 · Cited by 1
“Sphingolipids (such as ceramides) [49] are not only essential components of cell membrane structure, but are also well-established lipotoxic molecules and inflammatory signaling mediators [50,51].”
Sphingolipid homeostasis and dysregulation in liver function and disease
Lan, J., Pan, Z., Dong, W. N., Wang, J., Zhang, C., Zhang, Y., Wu, Y., & Jin, J. N. (2026) · Life Metabolism · doi:10.1093/lifemeta/loag011 · Cited by 2
Hicks, D., & Whiley, L. (2026) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2026.10054 · Cited by 1
“23).”
Sun, Z., He, C., Ma, X., Wu, P., Wang, T., Yuan, J., Pu, Y., Zhou, X., Mei, Z., Song, H., et al. (2026) · iMeta · doi:10.1002/imt2.70166 · Cited by 1
Seyedebrahimi, S. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819528-4.00006-7 · Cited by 1
Overview of concepts of the sphingolipid metabolism
Стороженко, Г. В., Kharchenko, V., Krasilnikova, O. A., & Tkachenko, O. (2021) · ScienceRise Biological Science · doi:10.15587/2519-8025.2021.234699 · Cited by 1
“It is suggested that the development of pathologies is associated with imbalance of sphingolipids in cells and excessive accumulation of ceramides, while preventing the accumulation of ceramides in cells may prevent the emergence of cardiac and metabolic pathologies, including insulin resistance, cardiovascular diseas…”
BackgroundPavlovskyi, L. (2020) · GASTROENTEROLOGY · doi:10.22141/2308-2097.54.2.2020.206227
Birkenfeld, A. L., Stefan, N., & Roden, M. (2021) · Diabetes aktuell · doi:10.1055/a-1417-5784
“[4] Apostolopoulou M, Gordillo R, Koliaki C et al.”
BackgroundSelf-citationPerfil de esfingolipídios no câncer de cabeça e pescoço
Faedo, R. R. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.60.2021.tde-29092021-103246
Mucinski, J. M. (2022) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/93980
The Coffee Revolution: From Politics to Optimized Health
Barag, S., Viehoever, A. R., Kawashima, T., Ko, A., Sanchez, D., Stull, C., & Nadeau, D. (2023) · Journal of the Osteopathic Family Physicians of California · doi:10.58858/010102
Mubarak, S., Faruqi, A., Riaz, B., Naureen, T., Ali, U., & Yousufzai, M. I.-U.-A. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023172187
Yeast lipid droplet dynamics are coupled to sphingolipid biosynthesis via Tsc3pPreprint
Hertel, M., Mastrototaro, L., Martínez-Montañés, F., Ejsing, C. S., Beller, M., Markgraf, D. F., & Roden, M. (2023) · Research Square · doi:10.21203/rs.3.rs-2859060/v1
Self-citationRôle du récepteur RANK dans la régulation du métabolisme énergétique hépatique et adipocytaire
Phan, F. (2022) · theses.fr (ABES) · doi:10.70675/009ba81az6addz47b3z9e33zcc6ad1543dcb
Can Cardiovascular Risk Be Simply Estimated in Nonalcoholic Fatty Liver Disease Patients?
Özer, H., Baloğlu, İ., Öztürk, Y., Poyraz, N., & Türkmen, K. (2024) · Genel Tıp Dergisi · doi:10.54005/geneltip.1415989
Li, F., Wu, M., Wang, F., Luo, L., Wu, Z., Huang, Z., & Wen, Z. (2024) · Biomedical Engineering Letters · doi:10.1007/s13534-024-00442-8
Athanasopoulos, S., & Whyte, M. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111783
Ma, Z., Xu, C., Kang, X., Zhang, S., Li, H., Tao, L., Zheng, D., Guo, X., & Yang, X. (2020) · Figshare · doi:10.6084/m9.figshare.12010680
Denimal, D., Béland‐Bonenfant, S., de Barros, J.-P. P., Rouland, A., Bouillet, B., Duvillard, L., Vergès, B. L., & Petit, J. (2023) · Figshare · doi:10.6084/m9.figshare.24532019
Denimal, D., Béland‐Bonenfant, S., de Barros, J.-P. P., Rouland, A., Bouillet, B., Duvillard, L., Vergès, B. L., & Petit, J. (2024) · Figshare · doi:10.6084/m9.figshare.24532307
Denimal, D., Béland‐Bonenfant, S., de Barros, J.-P. P., Rouland, A., Bouillet, B., Duvillard, L., Vergès, B. L., & Petit, J. (2024) · Figshare · doi:10.6084/m9.figshare.26637564
Denimal, D., Béland‐Bonenfant, S., de Barros, J.-P. P., Rouland, A., Bouillet, B., Duvillard, L., Vergès, B. L., & Petit, J. (2024) · Figshare · doi:10.6084/m9.figshare.26637561
Denimal, D., Bergas, V., de Barros, J.-P. P., Simoneau, I., Demizieux, L., Passilly‐Degrace, P., Bouillet, B., Petit, J., Rouland, A., Bataille, A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22767305
Haberl, E. M., Pohl, R., Rein‐Fischboeck, L., Höring, M., Krautbauer, S., Liebisch, G., & Buechler, C. (2020) · Figshare · doi:10.6084/m9.figshare.13358075
Denimal, D., Béland‐Bonenfant, S., de Barros, J.-P. P., Rouland, A., Bouillet, B., Duvillard, L., Vergès, B. L., & Petit, J. (2024) · Figshare · doi:10.6084/m9.figshare.26637558
Ma, Z., Xu, C., Kang, X., Zhang, S., Li, H., Tao, L., Zheng, D., Guo, X., & Yang, X. (2020) · Figshare · doi:10.6084/m9.figshare.12010677
Diabetes mellitus tipo 2 y su interrelación con la enfermedad de hígado graso no alcohólico
Marín-Tirado, H. A., & Torres Cueva, G. D. L. Á. (2024) · Repositorio Institucional (Universidad de Cuenca)
Zhang, Y., Qian, C., Zeng, W., Liu, Y., & Wang, X. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.108178
Yin, J., Chongxuan, S. H. A. O., Cheng, L., Hong, Y., Li, Z., Li, C., Ban, X., & Gu, Z. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108239
Mason, E. J., Schraw, J. M., Woodhouse, J. P., Gramatges, M. M., Williams, K. J., Chen, B., Harrell, M. B., Taylor, O. A., Scheurer, M. E., Lupo, P. J., et al. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10414-6 · Cited by 1
“Studies have identified strong associations between specific lipid metabolites and liver disease in the general population [11–15].”
InfluentialFANG, Q., Yang, C., Yao, N., Xie, T., & Gong, X. (2026) · Nature Communications · doi:10.1038/s41467-026-71272-8
Homéostasie des céramides et hépatopathies métaboliques
Régnier, M. (2018) · theses.fr (ABES) · doi:10.70675/2fb92711z373cz4b27z8082z7aa3f8930e63 · Cited by 1
Impact de l'obésité sur la toxicologie des contaminants alimentaires : l'exemple de la Fumonisine B1
Dopavogui, L. (2022) · theses.fr (ABES) · doi:10.70675/8fcfcad7z134cz4df2zade9z155636aa8994 · Cited by 1
Rôle des sphingolipides hépatiques dans la physiopathologie du diabète de type 2
Lachkar, F. (2022) · theses.fr (ABES) · doi:10.70675/2f1ce169zade5z47ccz96caz55bf77edab09
Rigamonti, A. E., Dei, M., Signorelli, P., Bondesan, A., Caroli, D., Cella, S. G., & Sartório, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15103634
“Despite the clear differences observed at the group level, univariate regression analyses revealed only a limited number of significant associations between individual sphingolipids and cardiometabolic parameters after appropriate correction for multiple testing [41].”
Tu, Z., Ding, Y., Yue, T., Zhang, H., Peng, T., Yang, P., Qin, W., Wang, J., Weng, J., & Luo, S. (2026) · Hepatology International · doi:10.1007/s12072-026-11103-6
“In affected livers, oxidative stress upregulates enzymes like acid sphingomyelinase, converting sphingomyelin to cera-mides, which impair mitochondrial function, increase reactive oxygen species, and promote hepatocyte lipotoxicity and apoptosis [24, 25].”
Dhaou, C. B., Rom, O., & Orr, A. W. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101624
Impact of understudied PFAS on Lipid Metabolism in Hepatocyte 2D and 3D in vitro model
Kashobwe, L., Cenijn, P. H., Hamers, T., & Leonards, P. E. G. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117972
Miya, A., Tura, A., Shokouhmehr, A., Esposito, I., Yavas, A., Granderath, F. A., Schlensak, M., Huttasch, M., Xourafa, G., Heilmann, G., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113481
Self-citationYu, Y., Shan, Y., Chen, Y., Ding, L., & Qian, H. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c05063
Kotlyarov, S. N., Котлярова, А. А., Catanzaro, R., & Marotta, F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198614
Sun, Y., Liu, Y., Chen, X., 邓世洲, Zhang, N., Wu, F., Fan, D., Wang, Y., & Wang, Y. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00607-0
“When the liver’s capacity for lipid oxidation and export becomes overwhelmed [41, 42], toxic lipid intermediates, oxidative stress, and inflammatory responses intensify, ultimately driving the progression from simple steatosis to steatohepatitis and fibrosis [43, 44].”
Khan, A., Rajan, Malakar, D., Maan, K., Biswas, S., Sheikh, S. S., Bajaj, A., Shalimar, S., Gupta, I., & Dasgupta, U. (2026) · Communications Health · doi:10.1038/s44528-026-00039-w
MKP ‐2 Genetic Depletion Modulates Adipose Lipid Composition, Cellular Senescence, and Aging in Mice
Welch, M., Ghimire, N., Smith, S., Secunda, C., Fink, A., Sleiman, A., Chambliss, L., Pinckard, C., Reyes, C., Katta, P., et al. (2026) · Aging Cell · doi:10.1111/acel.70794
Metadata
- Authors
- Apostolopoulou, M., Gordillo, R., Koliaki, C., Gancheva, S., Jelenik, T., De Filippo, E., Herder, C., Markgraf, D., Jankowiak, F., Esposito, I., Schlensak, M., Scherer, P. E., & Roden, M.
- Affiliations
- Deutsches Diabetes-Zentrum e.V. (DE)
- The University of Texas Southwestern Medical Center (US)
- Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany
- Heinrich Heine University Düsseldorf (DE)
- Institute of Pathology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany
- Corresponding author
- Roden, Michael
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-03-30
- Volume
- 41
- Issue
- 6
- Pages
- 1235-1243
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2794512033
- Cited by
- 284
- References
- 37
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 41 · 2023: 33 · 2022: 46 · 2021: 35 · 2020: 50 · 2019: 31 · 2018: 10
- FWCI
- 24.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Research of the State of North Rhine-Westfalia
- German Federal Ministry of Health
- Federal Ministry for Research (BMBF) to the German Center for Diabetes Research
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, sphingolipids, ceramide, dihydroceramide, lactosylceramide, sphinganine, sphingomyelin, insulin resistance, hepatic insulin sensitivity, oxidative stress, lipid peroxidation, c-Jun N-terminal kinase, inflammation, mitochondrial function, obesity
- MeSH terms
- Adult, Animals, Female, Humans, Inflammation, Insulin Resistance, Liver, Male, Middle Aged, Obesity, Oxidation-Reduction, Prospective Studies, Sphingolipids, Lipid Peroxidation, Glucose Clamp Technique, Oxidative Stress, Disease Progression, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.